隔離性大動脈吐症の高齢患者に対するトランスキャテーター大動脈弁置換
José C González1, Ignacio J Amat1,2
1University Clinic Hospital of Valladolid, Spain.
Journal of geriatric cardiology : JGC
|September 2, 2025
まとめ
トランスキャテーター大動脈弁置換 (TAVR) は,特に高リスク患者の大動脈吐 (AR) の有効な治療法です. 専用デバイスと オフラベルデバイスは有望ですが 最適な結果を得るためにさらなる研究が必要です
科学分野:
- 介入心臓科
- 心血管外科
- 医療機器
背景:
- 大動脈吐症 (AR) は,介入性心臓病学においてユニークな課題を提示しています.
- トランスキャセータ性大動脈弁置換 (TAVR) は,ARの手術による修復の代替手段として登場しています.
- ARの TAVR 患者の選択は,解剖学的および病理学的要因を慎重に考慮する必要があります.
研究 の 目的:
- 大動脈吐 (AR) の管理における TAVR の進化する役割を調べる.
- TAVRの安全性とARに対する手術による大動脈弁置換 (SAVR) の有効性を比較する.
- AR患者におけるTAVRの技術的ニュアンスとデバイスの検討について議論します.
主な方法:
- ARのTAVRに関する現在の文献,症例シリーズ,および登録データのレビュー.
- ARと大動脈狭窄症 (AS) の解剖学的および病理学的差異の分析
- AR治療に使用される専用および非標識TAVRデバイスの評価
主要な成果:
- 専用TAVR装置 (J-Valve,JenaValve) は,残留ARを減らすのに有望な結果を示しています.
- "Off-label" TAVRデバイスは,特に大きな大動脈環では,デバイスの成功率が良好です.
- TAVRは,SAVRと比較して,高リスクのAR患者にとって,安全で効果的な選択肢の可能性があることを示しています.
結論:
- TAVRはARの患者,特に手術のリスクが高い患者や弱体に対して有効な治療法です.
- ARにおけるTAVRの決定的な役割を確立し,デバイスの選択を導くために,さらなるランダム化試験が必要である.
- 現在進行中の研究は,AR管理のためのTAVR技術と長期的成果を精錬することを目的としています.
関連する概念動画
Aortic Regurgitation III: Medical Management
42
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
42
Aortic Regurgitation I: Introduction
36
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
36
Aortic Regurgitation IV: Nursing Management
55
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
55
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
52
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52
Mitral Regurgitation III: Medical Management
28
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
28
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21


